SINGAPORE (Mar 4): The MiFid II regulation introduced by the European Union at the start of last year changed the way research on companies gets paid for, prompting warnings that the amount and quality of analysis of small firms would suffer. Instead, the sell side seems to have risen to the challenge by widening its net.

The Markets in Financial Instruments Directive, which obliges investment managers to separate what they pay for research provided by the sell-side community from what they spend on trading fees, stoked concern that large companies would monopolise analysts’ attention.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook